|
GAS2L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.50299822271927E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.214870E-04 |
| Normal-vs-Stage2 |
4.238600E-03 |
| Normal-vs-Stage3 |
6.237900E-04 |
| Normal-vs-Stage4 |
9.040600E-03 |
| Stage1-vs-Stage2 |
5.367000E-01 |
| Stage1-vs-Stage3 |
1.921570E-02 |
| Stage1-vs-Stage4 |
2.132800E-01 |
| Stage2-vs-Stage3 |
5.662200E-02 |
| Stage2-vs-Stage4 |
2.728400E-01 |
| Stage3-vs-Stage4 |
3.737800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19869999481992E-08 |
| Normal-vs-AfricanAmerican |
2.211400E-04 |
| Normal-vs-Asian |
7.794100E-02 |
| Caucasian-vs-AfricanAmerican |
7.327600E-01 |
| Caucasian-vs-Asian |
7.038200E-01 |
| AfricanAmerican-vs-Asian |
7.900800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.64029999477822E-08 |
| Normal-vs-Female |
1.60540000004872E-06 |
| Male-vs-Female |
1.332430E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.503400E-03 |
| Normal-vs-Extreme_Weight |
3.218100E-03 |
| Normal-vs-Obese |
1.7404700000001E-05 |
| Normal-vs-Extreme_Obese |
2.686600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.578800E-01 |
| Normal_Weight-vs-Obese |
4.914400E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.379800E-01 |
| Extreme_Weight-vs-Obese |
2.236800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.232400E-01 |
| Obese-vs-Extreme_Obese |
9.463300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.623700E-03 |
| Normal-vs-Age(41-60Yrs) |
3.49459999826607E-08 |
| Normal-vs-Age(61-80Yrs) |
1.366660E-04 |
| Normal-vs-Age(81-100Yrs) |
1.580430E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.364200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.277920E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.335600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.577810E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.982000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.659600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.87047999999912E-05 |
| Normal-VS-Type2 PRCC |
1.8714999999947E-05 |
| Normal-VS-KIRP CIMP |
1.882560E-03 |
| Normal-VS-Unclassified PRCC |
2.518100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.898000E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.836600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.094550E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.843200E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.815600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.177560E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.056600E-03 |
| Normal-vs-N1 |
1.589970E-04 |
| Normal-vs-N2 |
1.134800E-01 |
| N0-vs-N1 |
6.603900E-02 |
| N0-vs-N2 |
6.705800E-01 |
| N1-vs-N2 |
6.326000E-01 |
|
|
